AbbVie vs Elevance Health stock
Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.
AbbVie is more profitable. Elevance Health grows faster, is cheaper for its profits and has less debt.
Side by side
| AbbVie | Elevance Health | |
|---|---|---|
| $506 billion | $85.2 billion | |
| 6.9% | 2.8% | |
| +6.0% | +9.5% | |
| 119.7× | 15.1× | |
| 3.5 years | 2.3 years | |
| 12.0% | 8.7% | |
| 3.1% | 1.7% |
How we compare
Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.
More comparisons: AbbVie vs Gilead Sciences · AbbVie vs GSK · AbbVie vs Intuitive Surgical · AbbVie vs Johnson & Johnson · Elevance Health vs The Cigna Group · Elevance Health vs Eli Lilly · Elevance Health vs UnitedHealth

